Entry Point Capital, LLC Neuro Pace Inc Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding NPCE
# of Institutions
55Shares Held
19.8MCall Options Held
28.3KPut Options Held
300-
Kck Ltd. Tortola, D85.62MShares$38.4 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$23.3 Million0.62% of portfolio
-
Morgan Stanley New York, NY2.47MShares$16.9 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$16.6 Million1.86% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.14MShares$7.82 Million3.99% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $170M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...